UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.420-430

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology

Biochimica et biophysica acta. Molecular basis of disease, 2018-04, Vol.1864 (4), p.1270-1278

2018

Link zum Volltext

Verfügbarkeit prüfen

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Nature reviews. Gastroenterology & hepatology, 2020-09, Vol.17 (9), p.557-588

2020

Link zum Volltext

Verfügbarkeit prüfen

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

Journal of hepatology, 2022-05, Vol.76 (5), p.1109-1121

2022

Link zum Volltext

Verfügbarkeit prüfen

Current and novel therapeutic opportunities for systemic therapy in biliary cancer

British journal of cancer, 2020-09, Vol.123 (7), p.1047-1059

2020

Link zum Volltext

Verfügbarkeit prüfen

Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals

Radiologia medica, 2021-06, Vol.126 (6), p.894-899

2021

Link zum Volltext

Verfügbarkeit prüfen

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1738-1749

2014

Link zum Volltext

Verfügbarkeit prüfen

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1125-1143

2017

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database

Digestive and liver disease, 2019-05, Vol.51 (5), p.724-729

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies

International journal of molecular sciences, 2018-10, Vol.19 (10), p.3003

2018

Link zum Volltext

Verfügbarkeit prüfen

Role of cholangiocytes in primary biliary cirrhosis

Seminars in liver disease, 2014-08, Vol.34 (3), p.273

2014

Link zum Volltext

Verfügbarkeit prüfen

Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology

Cells (Basel, Switzerland), 2020-03, Vol.9 (3), p.736

2020

Link zum Volltext

Verfügbarkeit prüfen

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

Journal of hepatology, 2022-10, Vol.77 (4), p.991-1004

2022

Link zum Volltext

Verfügbarkeit prüfen

Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2−/− mice by diminishing senescence of cholangiocytes

Laboratory investigation, 2018-11, Vol.98 (11), p.1449-1464

2018

Link zum Volltext

Verfügbarkeit prüfen

Proliferating Cholangiocytes: A Neuroendocrine Compartment in the Diseased Liver

Gastroenterology (New York, N.Y. 1943), 2007, Vol.132 (1), p.415-431

2007

Link zum Volltext

Verfügbarkeit prüfen

Secretin Stimulates Biliary Cell Proliferation by Regulating Expression of MicroRNA 125b and MicroRNA let7a in Mice

Gastroenterology (New York, N.Y. 1943), 2014-06, Vol.146 (7), p.1795-1808.e12

2014

Link zum Volltext

Verfügbarkeit prüfen

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

Scientific reports, 2017-09, Vol.7 (1), p.12200-15, Article 12200

2017

Link zum Volltext

Verfügbarkeit prüfen

Lin28 and let-7: roles and regulation in liver diseases

American journal of physiology: Gastrointestinal and liver physiology, 2016-05, Vol.310 (10), p.G757-G765

2016

Link zum Volltext

Verfügbarkeit prüfen

HCC development is associated to peripheral insulin resistance in a mouse model of NASH

PloS one, 2014-05, Vol.9 (5), p.e97136

2014

Link zum Volltext

Verfügbarkeit prüfen

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota

Metabolites, 2022-07, Vol.12 (7), p.647

2022

Link zum Volltext

Verfügbarkeit prüfen

The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities

Journal of clinical medicine, 2021-04, Vol.10 (8), p.1763

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances

Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

Current and novel therapeutic opportunities for systemic therapy in biliary cancer

Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline

Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database

Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies

MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

Role of cholangiocytes in primary biliary cirrhosis

Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2−/− mice by diminishing senescence of cholangiocytes

Proliferating Cholangiocytes: A Neuroendocrine Compartment in the Diseased Liver

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging

Secretin Stimulates Biliary Cell Proliferation by Regulating Expression of MicroRNA 125b and MicroRNA let7a in Mice

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

Lin28 and let-7: roles and regulation in liver diseases

HCC development is associated to peripheral insulin resistance in a mouse model of NASH

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota

The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities

Suchergebnisse filtern